异动解读 | 莫德纳盘中暴跌7.21%,疫苗业务前景不确定性引发投资者担忧

异动解读
11 Dec 2024

莫德纳公司(MRNA)周二盘中股价大跌7.21%,引发了市场的广泛关注。

分析人士指出,这一暴跌与投资者对莫德纳公司疫苗业务前景的担忧有关。美银美林重新给予莫德纳"跑输大盘"的评级,认为现阶段对于疫苗公司而言是一个艰难时期,莫德纳在新冠疫苗领域的收入来源存在不确定性。

此外,美银美林对于莫德纳公司后期管线项目的看法亦不太乐观,称对其后期产品管线抱有质疑。莫德纳核心产品新冠疫苗销售或将面临下滑,而公司其他在研项目前景也存在较大不确定性,这令投资者对该公司长期发展前景感到担忧,从而导致股价大幅下挫。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10